Participants in Kabatas’s study (60) were Turkish and were excluded if they had received immunomodulator treatment, had chronic renal, hepatic, or parathyroid diseases, had received intravitreal anti-VEGF injections within the previous month, or were undergoing antioxidant or vitamin D treatment. Here, VEGFA is linked to parathyroid gland disorder.